Aspirin resistance and adverse clinical events in patients with coronary artery disease.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  American Journal of Medicine

• Publication date

  2007-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.AMJMED.2006.10.021PMID 17602938
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of aspirin resistance in type 1 versus type 2 diabetes mellitus.

  2006cited by this paper
• Lack of effect of enteric coating on aspirin-induced inhibition of platelet aggregation in healthy volunteers.

  2006cited by this paper
• Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance.

  2006cited by this paper
• Aspirin to prevent heart attack and stroke: what's the right dose?

  2006cited by this paper
• Effect of Enteric Coating on Antiplatelet Activity of Low-Dose Aspirin in Healthy Volunteers

  2006cited by this paper
• Variability in platelet responsiveness to clopidogrel among 544 individuals.

  2005cited by this paper
• Prevalence of aspirin resistance in patients with type 2 diabetes

  2005cited by this paper
• Low-dose aspirin increases aspirin resistance in patients with coronary artery disease.

  2005cited by this paper
• Platelet-active drugs: the relationships among dose, effectiveness, and side effects.

  2004cited by this paper
• Clopidogrel Resistance Is Associated With Increased Risk of Recurrent Atherothrombotic Events in Patients With Acute Myocardial Infarction

  2004cited by this paper
• Platelet-active drugs : the relationships among dose, effectiveness, and side effects.

  2004cited by this paper
• Inhibition of platelet aggregation by aspirin progressively decreases in long-term treated patients.

  2004cited by this paper
• ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina).

  2003cited by this paper
• ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina).

  2003cited by this paper
• A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease.

  2003cited by this paper
• Incidence of aspirin nonresponsiveness using the Ultegra Rapid Platelet Function Assay-ASA.

  2003cited by this paper
• Aspirin Dosage and Thromboxane Synthesis in Patients with Vascular Disease

  2003cited by this paper
• ACC/AHA guideline for management of patients with chronic stable angina

  2003cited by this paper
• Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events

  2002cited by this paper
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

  2002cited by this paper
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

  2002cited by this paper
• Erratum: Myocardial infarction redefined - A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction (Journal of the American College of Cardiology (2000) 36 (959-969))

  2001cited by this paper
• Point-of-Care Measured Platelet Inhibition Correlates With a Reduced Risk of an Adverse Cardiac Event After Percutaneous Coronary Intervention: Results of the GOLD (AU-Assessing Ultegra) Multicenter Study

  2001cited by this paper
• Profile and prevalence of aspirin resistance in patients with cardiovascular disease.

  2001cited by this paper
• Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

  2000cited by this paper
• Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

  2000cited by this paper
• Effect of aspirin dosage and enteric coating on platelet reactivity.

  1997cited by this paper
• Development of Aspirin Resistance in Persons With Previous Ischemic Stroke

  1994cited by this paper
• Population variability in the effect of aspirin on platelet function. Implications for clinical trials and therapy.

  1994cited by this paper
• Effects of low-dose aspirin on in vitro platelet aggregation in the early minutes after ingestion in normal subjects.

  1994cited by this paper
• Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients.

  1993cited by this paper
• Effects of Low‐to‐High Doses of Aspirin on Platelet Aggregability and Metabolites of Thromboxane A2 and Prostacyclin

  1992cited by this paper
• Equal Antiplatelet Effects of Aspirin 50 or 324 mg/Day in Patients After Acute Myocardial Infarction

  1985cited by this paper

• Targeting MRP4 in drug resistance and aspirin treatment failure: implications for precision medicine.

  2026cites this paper
• Laboratory Resistance to Antiplatelet Therapy as Part of Secondary Prevention After Atherothrombotic Stroke in the Early Recovery Period (On the Example of Clinical Cases)

  2025cites this paper
• Efficacy of buffered acetylsalicylic acid and enteric-coated acetylsalicylic acid on platelet aggregation in patients with chronic coronary syndrome and type 2 diabetes (CASCADE): single-center observational comparative study

  2025cites this paper
• Interindividual variability in platelet reactivity among individuals with or without antiplatelet therapy: results from a large tertiary care hospital

  2024cites this paper
• Prospective, randomized, controlled, trial to assess ASA DOSing by body mass index in HEalthy volunteers (DOSE study)

  2023cites this paper
• Dual Antiplatelet Therapy: A Concise Review for Clinicians

  2023cites this paper
• Recurrent Coronary Artery Disease Due to Acetylsalicylic Acid Resistance May Be Related to COX-1 and COX-2 Mutations

  2022cites this paper
• Aspirin Resistance in Vascular Disease: A Review Highlighting the Critical Need for Improved Point-of-Care Testing and Personalized Therapy

  2022cites this paper
• Blood loss after coronary artery bypass by aspirin responsiveness assessed with preoperative VerifyNow aspirin testing

  2021cites this paper
• Platelet Activity Measured by VerifyNow® Aspirin Sensitivity Test Identifies Coronary Artery Bypass Surgery Patients at Increased Risk for Postoperative Bleeding and Transfusion.

  2020cites this paper
• PREVALENCE AND ASSOCIATED FACTORS OF ASPIRIN NON-RESPONSIVENESS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION IN DUHOK-IRAQ

  2020cites this paper
• Residual platelet reactivity in low-dose aspirin-treated patients with class 1 obesity.

  2020cites this paper
• Aspirin related platelet reactivity as a determinant of ten year survival in high risk non-ST segment elevation myocardial infarction (NSTEMI) patients.

  2020cites this paper
• Prevalence rate of laboratory defined aspirin resistance in cardiovascular disease patients: A systematic review and meta-analysis

  2020cites this paper
• Bedside-Monitoring der Blutgerinnung

  2019cites this paper
• Should the Argument About Aspirin Dosing be About Frequency Rather the Dose?

  2019cites this paper
• Circadian Rhythm of Cardiovascular Disease: The Potential of Chronotherapy With Aspirin

  2019cites this paper
• Platelet Function Testing in Clinical Research Trials

  2019cites this paper
• Aspirin Resistance: Cardiovascular Risk Game Changer.

  2019cites this paper
• Laboratory Monitoring of Antiplatelet Therapy

  2019cites this paper
• Association of Aspirin Resistance with Increased Mortality in Ischemic Stroke

  2019cites this paper
• Pharmacogenomic considerations for antiplatelet agents: the era of precision medicine in stroke prevention and neurointerventional practice

  2019cites this paper
• High Residual Platelet Reactivity during Aspirin Therapy in Patients with Non-St Segment Elevation Acute Coronary Syndrome: Comparison Between Initial and Late Phases

  2019cites this paper
• Assessing the efficacy of aspirin and clopidogrel in patients with acute coronary syndromes

  2018cites this paper
• Obesity and Altered Aspirin Pharmacology

  2018cites this paper
• Acetyl salicylic acid resistance and inhibition to platelet aggregation in normal healthy subjects

  2018influential citation
• Aspirin and clopidogrel high on‐treatment platelet reactivity and genetic predictors in peripheral arterial disease

  2018cites this paper
• Impact of high on‐aspirin platelet reactivity on outcomes following successful percutaneous coronary intervention with drug‐eluting stents

  2018cites this paper
• Aspirinresistenz Aspirinresistenz – Klinische Relevanz eines komplexen Phänomens

  2018cites this paper
• Investigating DHCR24 as a protector against cellular stress : more than just a cholesterol-synthesising enzyme

  2017cites this paper
• Monitoring of Antiplatelet Therapy

  2017cites this paper
• Global Trends in Aspirin Resistance‐Related Research from 1990 to 2015: A Bibliometric Analysis

  2017cites this paper
• Aspirin responsiveness changes in obese patients following bariatric surgery

  2017cites this paper
• Urinary 11-Dehydro-Thromboxane B2 and Mortality in Patients With Stable Coronary Artery Disease.

  2017cites this paper
• Platelet Function Testing: A Role for Personalised Therapy in Coronary Disease.

  2017cites this paper
• Assessing Risk in Patients with Stable Coronary Disease: When Should We Intensify Care and Follow-Up? Results from a Meta-Analysis of Observational Studies of the COURAGE and FAME Era

  2016cites this paper
• Aspirin Resistance Predicts Adverse Cardiovascular Events in Patients with Symptomatic Peripheral Artery Disease.

  2016cites this paper
• Carotid Endarterectomy on Antiplatelet Agents in the Era of Point-of-Care Testing.

  2016cites this paper
• Reduced aspirin responsiveness as assessed by impedance aggregometry is not associated with adverse outcome after cardiac surgery in a small low-risk cohort

  2016cites this paper
• High prevalence of aspirin resistance in elderly patients with cardiovascular disease and metabolic syndrome

  2016cites this paper
• Platelet-Mediated Thrombosis: From Bench to Bedside.

  2016cites this paper
• Platelet response to increased aspirin dose in patients with persistent platelet aggregation while treated with aspirin 81 mg

  2016cites this paper
• Oporność na leki przeciwpłytkowe : przyczyny i możliwości diagnostyki

  2016cites this paper
• Aspirin responsiveness and 6-month clinical outcome observed in a cohort study of patients with unstable angina pectoris

  2016cites this paper
• INFLUENCE OF CHRONIC KIDNEY DISEASE ON THE HAEMOSTATIC PROPERTIES, THE PLATELET TRANSCRIPTOMIC AND PLASMA PROTEOMIC PROFILES OF CORONARY ARTERY DISEASE PATIENTS

  2016cites this paper
• Utility of the Aspirin and P2Y12 Response Assays to Determine the Effect of Antiplatelet Agents on Platelet Reactivity in Traumatic Brain Injury

  2016cites this paper
• The protetive role of aspirin in patients with acute ischemic stroke

  2016cites this paper
• Clinical Significance of Laboratory-determined Aspirin Poor Responsiveness After Primary Percutaneous Coronary Intervention

  2016cites this paper
• Evaluating resistance to acetyl salicylic acid using platelet function test in patients with ischemic stroke at Cipto Mangunkusumo Hospital.

  2015cites this paper
• Aspirin Resistance in the Acute Stages of Acute Ischemic Stroke Is Associated with the Development of New Ischemic Lesions

  2015cites this paper
• Original basic researchSelective and rapid monitoring of dual platelet inhibition by aspirin and P 2 Y 12 antagonists by using multiple electrode aggregometry

  2015cites this paper
• The prognostic utility of tests of platelet function for the detection of 'aspirin resistance' in patients with established cardiovascular or cerebrovascular disease: a systematic review and economic evaluation.

  2015influential citation
• State-of-the-Art: Hypo-responsiveness to Oral Antiplatelet Therapy in Patients with Type 2 Diabetes Mellitus

  2015cites this paper
• Time-Dependent Effects of Aspirin on Blood Pressure and Morning Platelet Reactivity: A Randomized Cross-Over Trial

  2015cites this paper
• Effect of aspirin intake at bedtime versus on awakening on circadian rhythm of platelet reactivity

  2014cites this paper
• Non-HDL cholesterol is an independent risk factor for aspirin resistance in obese patients with type 2 diabetes.

  2014cites this paper
• Resistance to acetylsalicylic acid in patients with type 2 diabetes mellitus is associated with lipid disorders and history of current smoking

  2014cites this paper
• Aspirin Resistance and Newer Combatants against It

  2014cites this paper
• Assessment of platelet function: Laboratory and point-of-care methods

  2014cites this paper
• Human neutrophil α-defensins are associated with adenosine diphosphate-inducible neutrophil-platelet aggregate formation and response to clopidogrel in patients with atherosclerosis.

  2014cites this paper
• effect of aspirin intake on awakening or at bedtime on circadian rhythm of platelet reactivity in healthy subjects: a randomized cross-over trial

  2014cites this paper
• Modern Clinical Research: Guidelines for the Practicing Clinician or Source of Confusion?

  2013cites this paper
• Current Concepts in the Clinical Utility of Platelet Reactivity Testing.

  2013cites this paper
• Esomeprazole and aspirin fixed combination for the prevention of cardiovascular events

  2013cites this paper
• Differential impact of inflammation on six laboratory assays measuring residual arachidonic acid-inducible platelet reactivity during dual antiplatelet therapy.

  2013cites this paper
• A Comparison of VerifyNow® with PlateletMapping® -Detected Aspirin Resistance and Correlation with Urinary Thromboxane

  2013cites this paper
• Predictors of successful acetylsalicylic acid resistance suppression after percutaneous coronary revascularisation.

  2013cites this paper
• Vascular and platelet responses to aspirin in patients with coronary artery disease

  2013cites this paper
• Antiplatelet drug resistance and variability in response: the role of antiplatelet therapy monitoring.

  2013cites this paper
• Factors influencing Multiplate whole blood Impedance Platelet Aggregometry measurements, during aspirin treatment in acute ischemic stroke: a pilot study

  2013cites this paper
• Acute Ischaemic Stroke Agnieszka Anna Ardelt

  2013cites this paper
• Alta atividade plaquetária residual em resposta ao ácido acetilsalicílico em pacientes com síndrome isquêmica miocárdica instável sem supradesnível de ST: comparação entre as fases aguda e tardia

  2013cites this paper
• Antiplatelet Drugs Resistance and Correlation in Patients Presenting with Acute Coronary Syndrome

  2013cites this paper
• Evaluation of the Effectiveness of the AggreGuide A-100 in Measuring Platelet Aggregation in Individuals Taking a High or Low Dose of Aspirin

  2013cites this paper
• Prevalence of Aspirin Resistance and Clinical Characteristics in Patients with Cerebral Infarction

  2013cites this paper
• OCENA OPORNO ŚCI NA SKOJARZONE LECZENIE PRZECIWPËYTKOWE U CHORYCH Z TROPONINODODATNIM OSTRYM ZESPOËEM WIE ŃCOWYM LECZONYCH INWAZYJNIE

  2013cites this paper
• Relation of aspirin response to age in patients with stable coronary artery disease.

  2013cites this paper
• Antiplatelet Therapy

  2013cites this paper
• Aspirin intake at bedtime: does it lower blood pressure and morning platelet reactivity in patients with stable cardiovascular disease? A randomized cross-over trial

  2013cites this paper
• Increased platelet aggregation and serum thromboxane levels in aspirin-treated patients with prior myocardial infarction

  2012cites this paper
• Aspirin's Effect on Platelet Inhibition in Migraineurs

  2012cites this paper
• The prevalence, risk factors and prognosis of aspirin resistance in elderly male patients with cardiovascular disease

  2012cites this paper
• High on treatment platelet reactivity against aspirin by non-steroidal anti-inflammatory drugs – pharmacological mechanisms and clinical relevance

  2012cites this paper
• Renal function and aspirin resistance in patients with coronary artery disease.

  2012influential citation
• Research Submission Aspirin ’ s Effect on Platelet Inhibition in Migraineurshead

  2012cites this paper
• Impact of platelet reactivity on long-term clinical outcomes and bleeding events in Japanese patients receiving antiplatelet therapy with aspirin.

  2012cites this paper
• Current antithrombotic treatment in East Asia: Some perspectives on anticoagulation and antiplatelet therapy

  2012cites this paper
• Resistance to low‐dose aspirin therapy among patients with acute coronary syndrome in relation to associated risk factors

  2012cites this paper
• Assessment of platelet function in patients on antiplatelet therapy undergoing cardiac surgery: a review.

  2012cites this paper
• Low-DoseAspirinTherapy forCardiovascularPrevention Quantification and Consequences of Poor Compliance or Discontinuation

  2012cites this paper
• Oral antiplatelet therapy for atherothrombotic disease: overview of current and emerging treatment options

  2012cites this paper
• Frequency, Risk Factors, Prognosis, and Genetic Polymorphism of the Cyclooxygenase-1 Gene for Aspirin Resistance in Elderly Chinese Patients with Cardiovascular Disease

  2012cites this paper
• Effect of Triple Compared to Dual Antiplatelet Therapy AfterDrug-Eluting Stent Implantation in PercutaneousCoronary Intervention

  2012cites this paper
• ASPIRIN RESISTANCE AMONG PATIENTS WITH STABLE ISCHEMIC HEART DISEASE ASSESSED BY MEASUREMENT OF 11-DEHYDROTHROMBOXANE B2 IN URINE

  2012influential citation
• Clinical value of antiplatelet therapy in patients with acute coronary syndromes and in percutaneous coronary intervention.

  2011cites this paper
• Nonresponsiveness to Antiplatelet Therapy

  2011cites this paper
• Personalised Medicine in New Zealand: A new approach to healthcare delivery

  2011cites this paper
• Monitoring the effectiveness of antiplatelet therapy: opportunities and limitations.

  2011cites this paper
• Effect of Glucose or Fat Challenge on Aspirin Resistance in Diabetes

  2011influential citation
• Sex Differences in Antiplatelet Response in Ischemic Stroke

  2011cites this paper